RxFinder.ai

Nivolumab and Hyaluronidase-Nvhy

OPDIVO QVANTIG

Programmed Death Receptor-1 Blocking Antibody

NADAC/unit N/A
No Shortage

Nivolumab and Hyaluronidase-Nvhy helps the immune system fight cancer by blocking PD-1 immune checkpoints.

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.